Clinical trial
Fase 1 Study to Evaluate the Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers.
NCT01535443 is registered in ClinicalTrials.gov with Laboratorios Sophia S.A de C.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fase 1 Study to Evaluate the Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers.
- Lead sponsor
- Laboratorios Sophia S.A de C.V.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- October 31, 2011
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.